SCHEMBL24518979

SCHEMBL24518979

Oc1ccc2oc3c4ccccc4ccc3c2c1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.44
▸ CYP2C19 P33261 3/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ PTPN22 Q9Y2R2 1/20 0.42
▸ ABCG2 Q9UNQ0 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CSNK2A2 P19784 2/20 0.40
▸ CSNK2B P67870 2/20 0.40
▸ CSNK2A1 P68400 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ PSMD14 O00487 1/20 0.40
▸ CYP1A1 P04798 1/20 0.40
▸ CYP1B1 Q16678 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24519126 0.82 NPC1 (0.47) CYP2C19CYP3A4PTPN22ABCG2TDP1
SCHEMBL3265552 0.81 PTPN22 (0.50) MCL1CYP2C19CYP3A4TSHRPTPN22
SCHEMBL442615 0.79 L3MBTL1 (0.50) MCL1CYP2C19CYP3A4TSHRABCG2
SCHEMBL29612101 0.79 L3MBTL1 (0.50) MCL1CYP2C19CYP3A4TSHRABCG2
SCHEMBL3245672 0.79 CYP3A4 (0.47) MCL1CYP2C19CYP3A4TSHRABCG2
SCHEMBL22541881 0.79 MAOA (0.51) MCL1CYP2C19CYP3A4TSHRPTPN22
SCHEMBL20836043 0.76 MAOA (0.49) MCL1CYP3A4NPC1KDM4EHPGD
SCHEMBL24518921 0.76 ALOX5 (0.50) MCL1CYP2C19CYP3A4TSHRKDM4E
SCHEMBL24029538 0.76 L3MBTL1 (0.44) CYP2C19CYP3A4TSHRABCG2TDP1
SCHEMBL24518932 0.74 NPC1 (0.37) MCL1CYP2C19CYP3A4TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 MCL1 1400/4885CYP2C19 521/4885CYP3A4 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback